Journal of Diabetes and Its Complications

Article	Citations
The association between age at diagnosis of diabetes and development of diabetic retinopathy and assessment of healthcare access as an effect modifier	89
Confirmatory factor analysis including MRI-derived adipose tissues quantification improves associations of metabolic dysregulation to diastolic dysfunction	58
Protective effect of evolocumab on Müller cells in the rat retina under hyperglycaemic and hypoxic conditions	55
Letter to “Impact of remnant cholesterol and triglycerides on diabetes foot and disease in type 1 diabetes: A propensity score-matched case-control study”	55
Prognostic value of insulin resistance and hyperglycemia biomarkers for long-term risks of cardiometabolic outcomes	54
Changes in cardiac and vascular haemodynamics as potential mediators of improvements in cardiovascular and kidney outcomes with empagliflozin in type 2 diabetes	50
Assessing the influence of rural residence and economic distress on lower extremity risk stratification among diabetic foot ulcer patients utilizing the Wound, Ischemia, and Foot Infection (WIfI) clas	44
Individual and joint effects of diabetes and depression on incident cardiovascular diseases and all-cause mortality: Results from a population-based cohort study	43
The cardiovascular–kidney–metabolic staging in type 2 diabetes: the clock starts ticking early	42
Effect of fixed-dose combination of insulin degludec and liraglutide on apoB-containing lipoprotein subclasses and HDL lipidome in type 2 diabetes	39
Comparative analysis of the therapeutic effects of pregabalin, gabapentin, and duloxetine in diabetic peripheral neuropathy: A retrospective study	39
Atypical complications and co-morbidities of type 1 diabetes in young adults	38
Fatty acid synthase (Fasn) inhibits the expression levels of immune response genes via alteration of alternative splicing in islet cells	36
The correlation between patients with type 2 diabetes mellitus and chronic microvascular complications during the glucose peak time	34
Impact of dronedarone on patients with atrial fibrillation and diabetes: A sub-analysis of the ATHENA and EURIDIS/ADONIS studies	33
Non-alcoholic fatty liver disease and sarcopenia is associated with the risk of albuminuria independent of insulin resistance, and obesity	32
Effect of new glucose-lowering drugs on stroke in patients with type 2 diabetes: A systematic review and Meta-analysis	31
Effects of moderate-intensity aerobic training on cardiac structure and function in type 2 mellitus diabetic rats: Based on echocardiography and speckle tracking	31
A real-world experience with ranibizumab 0.5 mg initial intensive treatment for diabetic macular edema: 24-week outcomes of the RISING-K study	30
Nonlinear association of the hemoglobin glycation index with all-cause and cardiovascular mortality: A community-based cohort study	28
Contents/Barcode	28
Is subclinical cardiovascular disease linked with periodontal disease in diabetic and non-diabetic subjects?	28
Corrigendum to “The PanGut-study: Evoked potentials following rectal balloon distention, a way of evaluating diabetic autonomic neuropathy in the gut?” [J. Diabetes Complicat., Volume 37, Issue 5, May	26
Association of continuous subcutaneous insulin therapy and diabetic retinopathy in type 1 diabetes: A national cohort study	26
Relation of coronary calcium scoring with cardiovascular events in patients with diabetes: The CLARIFY Registry	25

The epidemiology of ketosis and low bicarbonate concentration in inpatients treated with sodium-glucose linked cotransporter inhibitors or dipeptidyl peptidase-4 inhibitors	25
Is HbA1c in the first trimester associated with adverse outcomes among pregnant Asian Indian women without gestational diabetes?	24
Multidisciplinary management of diabetic foot infection associated with improved 8-year overall survival	22
Echocardiographic evaluation of the effect of dapagliflozin on epicardial adipose tissue and left ventricular systolic function in type 2 diabetes mellitus	21
Growth differentiation factor-15: A marker for diabetic kidney disease in patients with metabolic-associated fatty liver disease	20
Pericardial fat pad detected on chest X-ray is closely associated with metabolic dysfunction-associated steatotic liver disease and visceral fat accumulation in patients with type 2 diabetes	20
Effect of the first and second COVID-19 associated lockdown on the metabolic control of patients with type 2 diabetes in Greece	19
Association of insomnia with incident chronic cognitive impairment in older adults with type 2 diabetes mellitus: A prospective study of the Hong Kong Diabetes Register	19
Contents/Barcode	19
Association of matrix metalloproteinase-10 levels and genetic variant rs17860955 with severe vascular complications in patients with type 1 diabetes: prospective cohort	18
Serum Isthmin-1 is negatively correlated with HDL-C in type 2 diabetes mellitus	18
The role of oral alpha-lipoic acid as an adjuvant antioxidant therapy in diabetic nephropathy among children and adolescents with type 1 diabetes: a randomized controlled trial	17
Methylglyoxal induces death in human brain neuronal cells (SH-SY5Y), prevented by metformin and dapagliflozin	17
The miR-200 family in type 2 diabetes: therapeutic and biomarker perspectives	16
Association between first-line monotherapy with metformin and the risk of atrial fibrillation (AMRAF) in patients with type 2 diabetes	16
Factors associated with adherence or nonadherence to insulin therapy among adults with type 2 diabetes mellitus: A scoping review	16
Heterogeneity of treatment effects of glucose-lowering drug classes for type 2 diabetes: LEGEND-T2DM network real-world evidence	16
Cytokine gene variants of TNF-α and IL-10 in the propensity of type 2 diabetes in south Indian population	16
A comparative analysis of cost-utility: Chiglitazar vs. sitagliptin in patients with type 2 diabetes in China	16
Inflammation level in type 2 diabetes is associated with dietary advanced glycation end products, Mediterranean diet adherence and oxidative balance score: A pathway analysis	16
The effects of SGLT2 inhibitors and GLP-1 receptor agonists on the triglyceride to HDL cholesterol ratio and the triglyceride-glucose index in patients with type 2 diabetes	15
Circulating proteomic markers are associated with measures of small and large fiber neuropathy and symptoms in type 2 diabetes	15
The association between birth weight, ponderal index, psychotropic medication, and type 2 diabetes in individuals with severe mental illness	15
Short-term effects of low-dose tirzepatide on lipid profile, glucose homeostasis and hepatic steatosis index in adults with obesity, but without diabetes mellitus: a prospective observational study	14
Response to the letter to the editor	14
Contents/Barcode	14
Contents/Barcode	14
Effect of dapagliflozin on liver and pancreatic fat in patients with type 2 diabetes and non-alcoholic fatty liver disease	14
Neuroinflammation and osteomyelitis in adults with Type 2 diabetes mellitus and peripheral neuropathy without and with foot lesions. What comes first?	14
Gestational diabetes mellitus and the subsequent risk of chronic kidney disease: A systematic review and meta-analysis	14
Diabetes and the treatment of ischemic stroke	13
Cumulative incidence of and risk factors for herpes zoster among patients with diabetes mellitus: Results from a 10-year nested case-control study	13
Circulating soluble CD163 as a potential biomarker of diabetes complications	13
A comparison of the ratios of C-reactive protein and triglycerides to high-density lipoprotein-cholesterol as biomarkers of metabolic syndrome in African Americans and non-Hispanic Whites	13
The PanGut-study: Evoked potentials following rectal balloon distention, a way of evaluating diabetic autonomic neuropathy in the gut?	13
Symptomatic diabetic autonomic neuropathy in type 1 diabetes (T1D): Findings from the T1D exchange	13
The effect of dapagliflozin therapy on ventricular repolarization parameters in electrocardiography in patients with diabetic cardiovascular disease	13
Highlighting the complex relationship between diabetes, renal function and bone health	13
Health status in stage B heart failure from diabetic cardiomyopathy baseline results from ARISE-HF	13
Reduced skeletal muscle mass to visceral fat area ratio is independently associated with reduced cognitive function in type 2 diabetes mellitus	12
Stepwise cardiovascular risk stratification in patients with type 2 diabetes based on coronary CT assessment	12
Contents/Barcode	12
Elastographic parameters of liver steatosis and fibrosis predict independently the risk of incident chronic kidney disease and acute myocardial infarction in patients with type 2 diabetes mellitus	12
Outcomes associated with a variable rate insulin infusion diabetic ketoacidosis protocol	12
Clinical features and outcomes of patients diagnosed with diabetic ketoacidosis (DKA) who were hospitalized for conditions outside of internal medicine	12
Transient albuminuria in the setting of short-term severe hyperglycemia in type 1 diabetes	12
Diabetic ketoacidosis and hyperosmolar hyperglycemic state in type 2 diabetes patients with severe kidney disease: a 7-year retrospective analysis	12
Semaglutide, central retinal thickness and continuous glucose monitoring in persons with type 2 diabetes: A post-hoc analysis from a randomised trial	12
Von Willebrand factor hyperactivity affects the outcome of lower limb revascularization in subjects with type 2 diabetes mellitus complicated by diabetic foot vasculopathy: An observational pilot stud	12
Role of profilin-1 in vasculopathy induced by advanced glycation end products (AGEs)	11

Effects of semaglutide and empagliflozin on oxygenation, vascular autoregulation, and central thickness of the retina in people with type 2 diabetes: A prespecified secondary analysis of a randomised	11
Effectiveness of adding glucagon-like peptide-1 receptor agonist on diabetes complications and mortality among basal insulin-treated people with type 2 diabetes: A real-world Korean study	11
Soluble Tumor Necrosis Factor Receptors (sTNFRs) as biomarkers for Diabetic Kidney Disease	11
Impact of SGLT2 inhibitors on the mechanisms of myocardial dysfunction in type 2 diabetes: A prospective non-randomized observational study in patients with type 2 diabetes mellitus without overt hear	11
PINK1 and oxidative stress in lean and obese patients with type 2 diabetes mellitus	11
Lower extremity amputation rates in patients with chronic kidney disease: A database study comparing patients with and without diabetes mellitus	11
Inhibition of IL-33 signaling ameliorate hepatic fibrosis with decreasing MCP-1 in a mouse model of diabetes and non-alcoholic steatohepatitis; comparison for luseogliflozin, an SGLT2 inhibitor	11
Contemporary prevalence of diabetic neuropathies in individuals with type 1 and type 2 diabetes in a Danish tertiary outpatient clinic	11
Achievement of low-density lipoprotein cholesterol goals in patients with diabetes-related foot ulceration	11
The effect of SGLT2 inhibitors, GLP1 agonists, and their sequential combination on cardiometabolic parameters: A randomized, prospective, intervention study	11
Associations of peroxisome proliferator-activated receptor-γ Pro12Ala polymorphism with non-alcoholic fatty liver disease: A meta-analysis	11
The effect of bariatric surgery on diabetes related foot complications among patients with type 2 diabetes: A systematic review	11
Temporal trends in non-traumatic lower extremity amputations (LEAs) and their association with 12-month mortality in people with diabetes, 2004–2016	10
Effects of moderate-intensity resistance exercise on blood glucose and pregnancy outcome in patients with gestational diabetes mellitus: A randomized controlled trial	10
Increased intracellular miR-142 in adults with Type 1 diabetes	10
High fat-induced the upregulation of LOX-1 in RF/6A cells under high glucose condition	10
Diabetes mellitus therapy in the light of oxidative stress and cardiovascular complications	10
Correlation of cerebral small vessel disease burden with outcome after lower extremity amputation	10
Implementation of evidence-based foot screening in people with diabetes: A scoping review	10
The legacy effect in early-stage diabetes: Don't stay by me, cardiovascular disease!	10
Prevalence of cardiovascular and renal comorbidities among patients with type 2 diabetes routinely treated in the primary care setting in Greece: An epidemiological study (the RECARDIA study)	10
The effect of vitamin D supplementation on cardiovascular risk in patients with prediabetes: A secondary analysis of the D2d study	10
Letter to the editor regarding “High rate of complications in a real-world cohort of youth with T2D: a multicenter analysis”	10
Associations of three diagnostic glycemic measures with all-cause and cardiovascular mortality in people not on antidiabetic medications: A prospective cohort study	10
Diabetic neuropathy in adolescents and young adults: The need for early detection and improved understanding	10
Contents/Barcode	10
Associations of modifiable lifestyle and clinical factors with cognitive function in adults with type 2 diabetes	10
Body-weight functional exercise promotes greater and safer blood glucose reduction compared to aerobic and strength exercises in type 1 diabetics: a randomised crossover study	10
Disease-modifying therapies for diabetic peripheral neuropathy: A systematic review and meta-analysis of randomized controlled trials	9
Unmet needs and opportunities for optimal management of patients with type 2 diabetes and chronic kidney disease	9
Efficacy of levocetirizine in reducing albuminuria and inflammatory biomarkers in patients with diabetic kidney disease: A randomized controlled trial	9
Contents/Barcode	9
Association between extrapolated time in range and large for gestational age infants in pregnant women with type 1 diabetes	9
Relationship between adiponectin and muscle mass in patients with metabolic syndrome and obesity	9
Prognostic importance of baseline and changes in serum uric acid for macro/microvascular and mortality outcomes in individuals with type 2 diabetes: The Rio de Janeiro type 2 diabetes cohort	9
Diabetic ketosis vs ketoacidosis as initial presentation of pediatric type 1 diabetes mellitus. Associated features and rate of progression during the first two years after diagnosis	9
Serum visfatin levels are positively correlated with dietary carbohydrate and polyunsaturated fatty acid intakes in type 2 diabetes mellitus patients	9
Contents/Barcode	9
Contents/Barcode	9
Fatty acid binding protein 1 (FABP1) and fatty acid binding protein 2 (FABP2) as a link between diabetic nephropathy and subclinical atherosclerosis in children and adolescents with type 1 diabetes	9
Understanding the mechanisms mediating cardio-renal benefit of empagliflozin in type 2 diabetes mellitus	9
Protein kinase C: A potential therapeutic target for endothelial dysfunction in diabetes	9
Development of clinical prediction models for renal and cardiovascular outcomes and mortality in patients with type 2 diabetes and chronic kidney disease using time-varying predictors	9
Association between Mediterranean diet adherence and peripheral artery disease in type 2 diabetes mellitus: An observational study	9
Time in range is associated with less hypoglycemia fear and higher diabetes technology acceptance in adults with well-controlled T1D	9
Relationship between relative fat mass and coronary artery calcification in patients with type 2 diabetes	9
The association of glucose control on in-hospital mortality in the cardiac intensive care unit	9
Systemic and ocular outcomes in patients with young-onset type 2 diabetes	9
Variability in the urinary albumin-to-creatinine ratio predicts mortality in patients with type 2 diabetes	8
Impaired cerebral hemodynamics and oxygenation in type 2 diabetes: insights into insulin resistance and hyperglycemia effects	8
Urinary A- and C-megalin predict progression of diabetic kidney disease: an exploratory retrospective cohort study	8
The role of circRNA in insulin resistance and its progression induced by adipose inflammation	8
Influence of type 2 diabetes mellitus on mortality in women with breast cancer: A matched case-control study	8
Progress in the treatment of vascular complications in type 2 diabetes by finerenone in combination with RAS inhibitors/SGLT-2i	8
Beyond pounds: What else could be lost?	8
The anti-inflammatory agent 5-ASA reduces the level of specific tsRNAs in sperm cells of high-fat fed C57BL/6J mouse sires and improves glucose tolerance in female offspring	8
Characterizing the relationship between social determinants of health and risk of albuminuria among children with type 1 diabetes	8
Kidney fat by magnetic resonance spectroscopy in type 2 diabetes with chronic kidney disease	8
Gender difference in association between diabetes mellitus and all-cause mortality in atrial fibrillation patients	8
Contents/Barcode	8
Variation in the hemoglobin glycation index	8
Pioglitazone increases risk of ischemic heart disease in patients with type 2 diabetes receiving insulin	8
Impact of Glucagon-like peptide 1 receptor agonists on peripheral arterial disease in people with diabetes mellitus: A narrative review	8
Effects of probiotics and fibers on markers of nephropathy, inflammation, intestinal barrier dysfunction and endothelial dysfunction in individuals with type 1 diabetes and albuminuria. The ProFOS Stu	8
The handgrip test – A historical test for diabetic autonomic neuropathy or a marker of something else?	8
Muscle mitochondrial function is impaired in adults with type 1 diabetes	8
Cost effectiveness of topical wound oxygen therapy for chronic diabetic foot ulcers	7
Sleep and eating patterns in individuals with gestational diabetes: associations with daily overnight and morning glucose using continuous glucose monitoring	7
Increased skeletal muscle mass index was involved in glycemic efficacy following diabetes treatment, and changes in fat mass index correlated with the changes in the lipid ratio in type 2 diabetes	7
Efficacy and safety of sodium glucose cotransporter 2 inhibitors plus standard care in diabetic kidney disease: A systematic review and meta-analysis	7
A comparative study of the relationship between time in range assessed by self-monitoring of blood glucose and continuous glucose monitoring with microalbuminuria outcome, HOMA-IR and HOMA-β test	7
High risk, low evidence: Need for more research on lipid-lowering therapies for people with type 1 diabetes	7
Effect of prior gestational diabetes on the risk of cardiovascular disease and death in women with type 2 diabetes: The Fremantle Diabetes Study Phase II	7
Gestational diabetes mellitus and hypertensive disorder of pregnancy play as spouse-pair risk factors of diabetes and hypertension: Insights from Tehran Lipid and Glucose Study	7
Impact of visit-to-visit glycated hemoglobin variability on diabetes distress and its subscales	7
Age different effects of SGLT2 inhibitors on body composition in individuals with type 2 diabetes: A retrospective cohort study	7
The effect of continuous glucose monitoring-guided glycemic control on progression of coronary atherosclerosis in type 2 diabetic patients with coronary artery disease: The OPTIMAL randomized clinical	7
Finerenone increases the likelihood of improved KDIGO risk category in patients with CKD and type 2 diabetes: An analysis from FIDELITY	7
Serum analysis of type 2 diabetes mellitus patients with low, moderate, and high risk of diabetic kidney disease using LC-MS metabolomics approach	7
Quantitative assessment of structural and functional changes in the carotid artery as vascular markers of gestational diabetes mellitus	7

The association of insulin responses and insulin sensitivity with cognition in adults with pre-diabetes: The Diabetes Prevention Program Outcomes Study	7
Diagnosis, management and impact of painful diabetic peripheral neuropathy: A patient survey in four European countries	7
Predicting the occurrence of DKA following sodium glucose co-transporter-2 inhibitors: An international cohort study	7
Predictors of liver fibrosis progression in cohort of type 2 diabetes mellitus patients with MASLD	7
Contents/Barcode	7
Slowly progressive subtype of childhood-onset type 1 diabetes as a high-risk factor for end-stage renal disease: A cohort study in Japan	7
Urogenital side effects in male subjects with type 2 diabetes treated with SGLT-2 inhibitors: A single centre, longitudinal observation	7
“It changed everything we do”: A mixed methods study of youth and parent experiences with a pilot exercise education intervention following new diagnosis of type 1 diabetes	7
Risk factors at admission of in-hospital dysglycemia, mortality, and readmissions in patients with type 2 diabetes and pneumonia	7
Prediction of worsening of renal function by the combination of an initial decline in renal function and blood pressure-lowering effect after renin–angiotensin system blockade in patients with type 2	7
DNA repair and inflammatory response genes play a central role in protecting patients with long-standing type 1 diabetes from vascular complications	7
Contents/Barcode	7
Uric acid in diabetic microvascular complications: Mechanisms and therapy	7
Cardiovascular events after a dramatic reduction of HbA1c in hospitalized subjects with type 2 diabetes and high long-term glucose exposure	7
All-cause mortality and factors associated with it in Finnish patients with type 1 diabetes	7
Type 2 diabetes mellitus in obesity promotes prolongation of cardiomyocyte contractile function, impaired Ca2+ handling and protein carbonylation damage	7
Long-term effects of l-serine supplementation upon a mouse model of diabetic neuropathy	7
Analysis of the therapeutic potential of miR-124 and miR-16 in non-alcoholic fatty liver disease	7
Obesity and its management in primary care setting	7